Anti-KRT14 antibody

Cat.#: 106119

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-KRT14 antibody
  • Documents
  • Description
    Mouse monoclonal to KRT14
  • Tested applications
    WB
  • Species reactivity
    Human Cytokeratin 14
  • Alternative names
    K14 antibody; Krt1-14 antibody; AI626930 antibody; Krt-1.14 antibody; K14 antibody; NFJ antibody; CK14 antibody; EBS3 antibody; EBS4 antibody
  • Isotype
    Mouse IgG
  • Preparation
    This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, the synthetic peptide corresponding to the N-terminus of the Human Cytokeratin 14. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
  • Clonality
    Monoclonal
  • Formulation
    0.2 μm filtered solution in PBS with 5% trehalose
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    WB: 0.2-0.5 μg/mL

  • Validations

    Cytokeratin 14 Antibody, Mouse MAb, Western blot

    Cytokeratin 14 Antibody, Mouse MAb, Western blot

  • Background
    Cytokeratin 14, also known as Keratin 14 and K14, is a member of the keratin family. Cytokeratin 14 is a type I keratin. It is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Cytokeratin 14 is mainly expressed in the basal layer. It is also strongly expressed in the outer root sheath of anagen follicles. Cytokeratin 14 and keratin 5 may have a role in maintenance of cell proliferation potential in the basal layer of stratified epithelia, modulating phosphatidylinositol 3-kinase/Akt–mediated cell proliferation and/or Notch1-dependent cell differentiation. Cytokeratin 14 defect prevents it from working effectively with keratin 5 and interfering with the assembly of the keratin intermediate filament network. A disruption in this network makes keratinocytes fragile and prone to rupture. Minor trauma to the skin, such as rubbing or scratching, can cause these cells to break down, resulting in the formation of painful, fluid-filled blisters. Mutations in the K14 gene are also responsible for Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis.
  • References
    • Coulombe PA, et al., 1991, Cell. 66(6): 1301-11.
    • Schweizer J, et al., 2006, 174(2): 169-74.
    • Lugassy J, et al., 2006, Am J Hum Genet. 79(4): 724-30.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"